Our EpiFinder™ platform gives researchers unprecedented insights into epigenetic studies for biomedical research, drug discovery and development, diagnostics, and precision medicine. With the ability to generate quantitative data at scale, faster, and more cost-efficiently than ever before, EpiFinder is ushering in a new era in epigenetics.

Epigenica is building a portfolio of products based on the EpiFinder platform, offering the first commercial kits using a single platform technology for comprehensive genome-wide profiling, high-throughput epigenetic screening, as well as blood-based epigenomics.